Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia
Author:
Funder
FCT/MEC
ERDF
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference48 articles.
1. Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring;Jabbour;Am. J. Hematol.,2016
2. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype;Melo;Blood,1996
3. An e6a2 BCR-ABL fusion transcript in a CML patient having an iliac chloroma at initial presentation;Torres;Leuk. Lymphoma,2007
4. Current trends in molecular diagnostics of chronic myeloid leukemia;Vinhas;Leuk. Lymphoma,2017
5. Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib;Hanfstein;Haematologica,2014
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cerium oxide nanoparticles-assisted aptasensor for chronic myeloid leukaemia detection;ADMET and DMPK;2024-08-18
2. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12
3. Assessing the gene silencing potential of AuNP-based approaches on conventional 2D cell culture versus 3D tumor spheroid;Frontiers in Bioengineering and Biotechnology;2024-02-12
4. The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia;Pathology - Research and Practice;2024-02
5. Gold nanoparticles for delivery of nucleic acid constructs for cancer treatment;Gold Nanoparticles for Drug Delivery;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3